TD Asset Management
VNDA icon

TD Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

TD Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,781
Closed -$262K – 1499
2022
Q3 		$262K Buy
+26,781
New +$283K ﹤0.01% 1382
2015
Q2 		– Sell
-15,900
Closed -$148K – 1426
2015
Q1 		$148K Sell
15,900
-123,700
-89% -$1.4M ﹤0.01% 1355
2014
Q4 		$2M Buy
139,600
+20,400
+17% +$241K ﹤0.01% 846
2014
Q3 		$1.24M Buy
119,200
+3,300
+3% +$43.3K ﹤0.01% 875
2014
Q2 		$1.88M Buy
115,900
+55,400
+92% +$738K ﹤0.01% 837
2014
Q1 		$983K Buy
60,500
+13,300
+28% +$189K ﹤0.01% 908
2013
Q4 		$586K Buy
+47,200
New +$474K ﹤0.01% 977

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TD Asset Management's VNDA Position: Q4 2022 in Review

TD Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2022, closing a stake of 26,781 shares — an estimated $262K sold.

TD Asset Management first reported a position in VNDA in Q4 2013 and held it in 7 quarters. The position peaked at $2M in Q4 2014. 190 funds tracked by Wall St. Rank hold VNDA as of Q4 2022.

  • TD Asset Management reported no remaining Vanda Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • TD Asset Management sold 26,781 Vanda Pharmaceuticals shares in Q4 2022, an estimated $262K.
  • TD Asset Management first reported a position in Vanda Pharmaceuticals in Q4 2013 and held it in 7 quarters.
  • TD Asset Management's Vanda Pharmaceuticals position peaked at $2M in Q4 2014.
  • 190 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2022.

Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.